AU673237B2 - Derivatized calcitonins - Google Patents

Derivatized calcitonins

Info

Publication number
AU673237B2
AU673237B2 AU59629/94A AU5962994A AU673237B2 AU 673237 B2 AU673237 B2 AU 673237B2 AU 59629/94 A AU59629/94 A AU 59629/94A AU 5962994 A AU5962994 A AU 5962994A AU 673237 B2 AU673237 B2 AU 673237B2
Authority
AU
Australia
Prior art keywords
compound according
group
thr
calcitonin
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59629/94A
Other languages
English (en)
Other versions
AU5962994A (en
Inventor
Virender Labroo
Tomikazu Sasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Zymogenetics Inc
Original Assignee
University of Washington
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Zymogenetics Inc filed Critical University of Washington
Publication of AU5962994A publication Critical patent/AU5962994A/en
Application granted granted Critical
Publication of AU673237B2 publication Critical patent/AU673237B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57527—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU59629/94A 1992-12-31 1993-12-30 Derivatized calcitonins Ceased AU673237B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99974992A 1992-12-31 1992-12-31
US999749 1992-12-31
PCT/US1993/012692 WO1994015962A2 (en) 1992-12-31 1993-12-30 Derivatized calcitonins

Publications (2)

Publication Number Publication Date
AU5962994A AU5962994A (en) 1994-08-15
AU673237B2 true AU673237B2 (en) 1996-10-31

Family

ID=25546645

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59629/94A Ceased AU673237B2 (en) 1992-12-31 1993-12-30 Derivatized calcitonins

Country Status (9)

Country Link
EP (1) EP0677062A1 (ja)
JP (1) JPH08505393A (ja)
KR (1) KR100310280B1 (ja)
AU (1) AU673237B2 (ja)
CA (1) CA2153071C (ja)
FI (1) FI953255A (ja)
NO (1) NO952608L (ja)
NZ (1) NZ261052A (ja)
WO (1) WO1994015962A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962270A (en) 1996-02-06 1999-10-05 Bionebraska, Inc. Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3798203A (en) * 1969-10-22 1974-03-19 Ciba Geigy Corp Analogues of human thyrocalcitonin modified with corresponding amino acids of salmon thyrocalcitonin and derivatives thereof
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
GB2184729A (en) * 1985-12-04 1987-07-01 Sandoz Ltd Calcitonin derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1806135A1 (de) * 1967-11-09 1969-07-17 Ciba Geigy Neue hypocalcaemische Peptide und Verfahren zu ihrer Herstellung
EP0297159A1 (en) * 1987-07-01 1989-01-04 Armour Pharmaceutical Company [N-Acyl, 1,7-Di-Aline] calcitonins, method for their preparation, pharmaceutical compositions and use
DE3876022T2 (de) * 1987-07-08 1993-04-22 Mitsubishi Petrochemical Co Calcitonin-derivate und deren salze.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
US3798203A (en) * 1969-10-22 1974-03-19 Ciba Geigy Corp Analogues of human thyrocalcitonin modified with corresponding amino acids of salmon thyrocalcitonin and derivatives thereof
GB2184729A (en) * 1985-12-04 1987-07-01 Sandoz Ltd Calcitonin derivatives

Also Published As

Publication number Publication date
FI953255A0 (fi) 1995-06-30
FI953255A (fi) 1995-06-30
WO1994015962A2 (en) 1994-07-21
JPH08505393A (ja) 1996-06-11
AU5962994A (en) 1994-08-15
WO1994015962A3 (en) 1994-09-29
CA2153071A1 (en) 1994-07-21
KR100310280B1 (ko) 2002-02-28
NO952608D0 (no) 1995-06-29
EP0677062A1 (en) 1995-10-18
NZ261052A (en) 1997-10-24
CA2153071C (en) 2000-05-30
NO952608L (no) 1995-08-30
KR960700273A (ko) 1996-01-19

Similar Documents

Publication Publication Date Title
EP0468337B1 (en) DNA coding for a human vasoconstrictive peptide and use thereof
US5580953A (en) Amylin antagonist peptides and uses therefor
EP0366016B1 (en) Endothelin DNA and use thereof
US6025467A (en) Parathyroid hormone derivatives and their use
JPH06184198A (ja) ペプチド類
US5093233A (en) Antagonists with position 13 modification
US5049654A (en) Calcitonin gene related peptide derivatives
WO1988006598A1 (en) Vasoactive intestinal peptide analogs
JP2013507414A (ja) 神経ペプチド−２受容体（ｙ−２ｒ）アゴニスト
US8759299B2 (en) Analogues of insulin-like growth factor-1 (IGF-1) having amino acid substitution at position 59
US5149779A (en) Humoral hypercalcemic factor antagonists
US4824937A (en) Synthetic natriuretic peptides
AU8237187A (en) Derivatives of atrial natriuretic peptides
JPH0222292A (ja) 高カルシウム体液性因子拮抗薬
EP0315687B1 (en) (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin
US5710244A (en) Derivatized calcitonins
AU673237B2 (en) Derivatized calcitonins
US5087562A (en) Humoral hypercalcemic factor antagonists with modification at position 13 . . .
WO2011011073A1 (en) Site-specific pegylated or site-specific lipidated igf-1 and analogues of igf-1
EP0300737B1 (en) Calcitonin gene related peptide derivatives
Zarandi et al. Synthesis and in vitro and in vivo activity of analogs of growth hormone‐releasing hormone (GH‐RH) with C‐terminal agmatine
US5087561A (en) Humoral hypercalcemic factor antagonists modified at position 13 by biotin
JPH07149794A (ja) 直鎖状付着阻害剤
JPS63126894A (ja) カルシトニン遺伝子関連ペプチド
JPH04368396A (ja) 新規なカルシトニン遺伝子関連ペプチド誘導体

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired